Showing results (341-350 of 357) with videos related to
Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2024
A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial CancerRandy F Sweis, Gurkamal S Chatta, Rohit K Jain, et al.Evolution; International Journal of Organic Evolution|April 24, 2012
Do trade-offs have explanatory power for the evolution of organismal interactions?Mark K Asplen, Emily Bruns, Aaron S David, et al.Medical Microbiology and Immunology|June 19, 2012
Performance evaluation of a new fourth-generation HIV combination antigen-antibody assayA Mühlbacher, H Schennach, J van Helden, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|June 3, 2008
Improvement of modelling capabilities for assessing urban contamination: the EMRAS Urban Remediation Working GroupK M Thiessen, B Batandjieva, K G Andersson, et al.International Journal of Geriatric Psychiatry|December 19, 2001
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical dataJ S Kennedy, F P Bymaster, L Schuh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2017
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid TumorsJeffrey S Miller, Chihiro Morishima, Douglas G McNeel, et al.Journal for Immunotherapy of Cancer|February 6, 2025
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcomaRamya Ramaswami, Angela Shaulov Kask, Leonard D'Amico, et al.Bioorganic & Medicinal Chemistry Letters|July 16, 2008
Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptaseZachary K Sweeney, Sahaja Acharya, Andrew Briggs, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid TumorsKim Margolin, Chihiro Morishima, Vamsidhar Velcheti, et al.Journal of Medicinal Chemistry|April 4, 2009
The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4'-azidocytidine against hepatitis C virus replication: the discovery of 4'-azido-2'-deoxy-2'-fluorocytidine and 4'-azido-2'-dideoxy-2',2'-difluorocytidineDavid B Smith, Genadiy Kalayanov, Christian Sund, et al.Pageof 36